Literature DB >> 2825797

Acid sphingomyelinase from human urine: purification and characterization.

L E Quintern1, G Weitz, H Nehrkorn, J M Tager, A W Schram, K Sandhoff.   

Abstract

Acid sphingomyelinase (sphingomyelin phosphodiesterase, EC 3.1.4.12) was purified from human urine in the presence of 0.1% Nonidet P-40. The activity could be enriched 23,000-fold by sequential chromatography on octyl-Sepharose, concanavalin A-Sepharose, blue Sepharose and DEAE-cellulose. The last purification step yielded an enzyme preparation with a specific activity of about 2.5 mmol sphingomyelin cleaved/h per mg protein and with a yield of about 3%. Purified sphingomyelinase appeared to be homogeneous in sodium dodecyl sulfate-polyacrylamide gel electrophoresis with a molecular mass of 70 kDa. In the presence of 0.08% (w/v) sodium taurodeoxycholate the preparation showed phosphodiesterase activity toward sphingomyelin, phosphatidylcholine and phosphatidylglycerol. These activities co-purified during the entire purification procedure, indicating that the acid sphingomyelinase hydrolyses not only sphingomyelin but also the other two phospholipids, phosphatidylcholine and phosphatidylglycerol. Addition of 100 microM tripalmitoylglycerol to the assay system (which contains 100 microM sphingomyelin) instead of detergent, stimulated the reaction about 20-fold compared to an assay which did not contain detergents, thus offering a very sensitive and efficient system for the assay of sphingomyelinase in a system free of detergents. Sphingomyelin degradation was strongly inhibited by phosphatidylinositol 4',5'-bisphosphate, adenosine 3',5'-diphosphate and adenine-9-beta-D-arabinofuranoside 5'-monophosphate (50% inhibition at inhibitor concentrations of 1-5 microM).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825797     DOI: 10.1016/0005-2760(87)90055-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

1.  A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing.

Authors:  Russell W Jenkins; Jolanta Idkowiak-Baldys; Fabio Simbari; Daniel Canals; Patrick Roddy; Clarke D Riner; Christopher J Clarke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development.

Authors:  Wilhelm Stoffel; Britta Jenke; Barbara Blöck; Markus Zumbansen; Jürgen Koebke
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-11       Impact factor: 11.205

3.  Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology.

Authors:  Thomas Kirkegaard; Anke G Roth; Nikolaj H T Petersen; Ajay K Mahalka; Ole Dines Olsen; Irina Moilanen; Alicja Zylicz; Jens Knudsen; Konrad Sandhoff; Christoph Arenz; Paavo K J Kinnunen; Jesper Nylandsted; Marja Jäättelä
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

4.  Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease.

Authors:  Markus Zumbansen; Wilhelm Stoffel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B.

Authors:  C Rodriguez-Lafrasse; M T Vanier
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 6.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

7.  Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat.

Authors:  Jan Lillienau; Yajun Cheng; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

8.  Occurrence of two molecular forms of human acid sphingomyelinase.

Authors:  K Ferlinz; R Hurwitz; G Vielhaber; K Suzuki; K Sandhoff
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

9.  Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann-Pick disease.

Authors:  K Ferlinz; R Hurwitz; M Weiler; K Suzuki; K Sandhoff; M T Vanier
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

10.  In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase.

Authors:  Jian-Jun Liu; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2002-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.